Keryx continues to seek to in-license or acquire additional clinical-stage drug candidates to bolster its portfolio.

Keryx has established an internal in-licensing team for the assessment of prospective in-licensing candidates from other companies and academic institutions. This team, coupled with the in-licensing track record and expertise of senior management, positions Keryx well for the identification of attractive clinical-stage compounds and the consummation of in-licensing transactions.

Interested parties should contact the company at BusDev@keryx.com to discuss potential opportunities.